Hunger Christina, Hilzinger Rebecca, Koch Theresa, Mander Johannes, Sander Anja, Bents Hinrich, Schweitzer Jochen
Center for Psychosocial Medicine, Institute for Medical Psychology, Heidelberg University Hospital, Bergheimer Straße 20, D-69115, Heidelberg, Germany.
Center for Psychological Psychotherapy, University of Heidelberg, Bergheimer Straße 58a, D-69115, Heidelberg, Germany.
Trials. 2016 Mar 31;17:171. doi: 10.1186/s13063-016-1252-1.
Social anxiety disorders are among the most prevalent anxiety disorders in the general population. The efficacy of cognitive behavioral therapy (CBT) for social anxiety disorders is well demonstrated. However, only three studies point to the efficacy of systemic therapy (ST) in anxiety disorders, and only two of them especially focus on social anxiety disorders. These ST studies either do not use a good comparator but minimal supportive therapy, they do not use a multi-person ST but a combined therapy, or they do not especially focus on social anxiety disorders but mood and anxiety disorders in general. Though ST was approved as evidence based in Germany for a variety of disorders in 2008, evidence did not include anxiety disorders. This is the first pilot study that will investigate multi-person ST, integrating a broad range of systemic methods, specifically for social anxiety disorders and that will compare ST to the "gold standard" CBT.
This article describes the rationale and protocol of a prospective, open, interventive, balanced, bi-centric, pilot randomized controlled trial (RCT). A total of 32 patients with a primary SCID diagnosis of social anxiety disorder will be randomized to either CBT or ST. Both treatments will be manualized. The primary outcome will include social anxiety symptoms at the end of therapy. Therapy will be restricted to no more than 26 hours (primary endpoint). Secondary outcomes will include psychological, social systems and interpersonal functioning, symptom adjustment, and caregiver burden, in addition to change measures, therapist variables and treatment adherence. At the secondary endpoints, 9 and 12 months after the beginning of therapy, we will again assess all outcomes.
The study is expected to pilot test a RCT which will be the first to directly compare CBT and multi-person ST, integrating a broad range of systemic methods, for social anxiety disorders, and it will provide empirical evidence for the calculation of the number of patients needed for a confirmatory RCT.
ClinicalTrials.gov: NCT02360033 ; date of registration: 21 January 2015.
社交焦虑障碍是普通人群中最常见的焦虑障碍之一。认知行为疗法(CBT)对社交焦虑障碍的疗效已得到充分证明。然而,仅有三项研究指出系统疗法(ST)对焦虑障碍有效,其中仅有两项特别关注社交焦虑障碍。这些关于系统疗法的研究要么未使用合适的对照,而是采用了最低限度的支持性疗法;要么未采用多人系统疗法,而是采用了联合疗法;要么并非特别关注社交焦虑障碍,而是总体上关注情绪和焦虑障碍。尽管系统疗法在2008年被德国批准为多种疾病的循证疗法,但证据并不包括焦虑障碍。这是第一项试点研究,将调查多人系统疗法,整合广泛的系统方法,专门针对社交焦虑障碍,并将系统疗法与“金标准”认知行为疗法进行比较。
本文描述了一项前瞻性、开放性、干预性、平衡性、双中心试点随机对照试验(RCT)的基本原理和方案。共有32名经结构性临床访谈诊断为社交焦虑障碍的患者将被随机分为认知行为疗法组或系统疗法组。两种治疗均采用手册化治疗。主要结局将包括治疗结束时的社交焦虑症状。治疗时间限制在不超过26小时(主要终点)。次要结局将包括心理、社会系统和人际功能、症状调整以及照顾者负担,此外还有变化测量、治疗师变量和治疗依从性。在次要终点,即治疗开始后9个月和12个月,我们将再次评估所有结局。
该研究预计将对一项随机对照试验进行试点测试,这将是第一项直接比较认知行为疗法和多人系统疗法(整合广泛的系统方法)治疗社交焦虑障碍的研究,并将为确证性随机对照试验所需的患者数量计算提供实证依据。
ClinicalTrials.gov:NCT02360033;注册日期:2015年1月21日。